BIOMAT Database Logo BIOMAT Database Logo

Clinical pharmacology of the neuromuscular junction. 1969

W L Nastuk

UI MeSH Term Description Entries
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D000758 Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.

Related Publications

W L Nastuk
Pharmacology of the neuromuscular junction.
April 1950, The Journal of pharmacology and experimental therapeutics,
W L Nastuk
Pharmacology of the neuromuscular junction.
January 1974, Acta anaesthesiologica Belgica,
W L Nastuk
[Neuromuscular junction: pharmacology, toxicology and clinical use of neuromuscular blocking agents].
March 1975, La Clinica terapeutica,
W L Nastuk
[Physiology and pharmacology of the neuromuscular junction].
June 1961, [Seitai no kagaku] [Science of the living body],
W L Nastuk
[Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication)].
January 1978, Neurologija,
W L Nastuk
The pharmacology of the excitatory neuromuscular junction in the crayfish.
January 1980, Progress in neurobiology,
W L Nastuk
The pharmacology of the piperidine dicarboxylates on the crustacean neuromuscular junction.
January 1984, Neuropharmacology,
W L Nastuk
Clinical neuromuscular pharmacology of pancuronium.
June 1971, Anesthesiology,
W L Nastuk
Clinical pharmacology of the neuromuscular blocking agents.
January 1991, DICP : the annals of pharmacotherapy,
W L Nastuk
Clinical neurophysiology of neuromuscular junction disease.
January 2019, Handbook of clinical neurology,
Copied contents to your clipboard!